REQUEST A DEMO
Total
USD $0.00
Search more companies

Newglab Pharma Co., Ltd. (South Korea)

Main Activities: Radio and Television Broadcasting and Wireless Communications Equipment Manufacturing
Full name: Newglab Pharma Co., Ltd. Profile Updated: November 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

HD Pro Co.,Ltd. is engaged in manufacturing and distribution of CCTV cameras. The company offers NVR / IP Camera, EX-SDI Camera, HD-SDI Camera, HD-SDI Zoom Camera, AHD Camera, TVI Camera, AHD DVR, 1000TVL Analog, CCTV Camera, Zoom Camera, PTZ Camera, PIR Sensor Camera, Identifier Camera, Hood IR Camera, Hood Camera, Outdoor Dome IR Camera, Outdoor Dome Camera, Indoor Dome IR Camera, Indoor Dome Camera, Box Camera Bullet / Miniature Camera, Night Vision Lamp, Color Module, Zeus-I Camera, Zeus-II Camera, W-6 Camera, Imax Camera, Effio-V Camera, LCD COMBO DVR / DVR, LCD Monitor, bracket/junction box and lens. HD Pro Co.,Ltd. is based in Bucheon, Gyeonggi-do Province, South Korea. The company was established in 2004.

Headquarters
23, Sinheung-Ro 362Beon-Gil, Bucheon-Si, Gyeonggi-Do
Bucheon; Gyeonggi;

Contact Details: Purchase the Newglab Pharma Co., Ltd. report to view the information.

Website: http://www.newglab.com

Basic Information
Total Employees:
Purchase the Newglab Pharma Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Newglab Pharma Co., Ltd. report to view the information.
Registered Capital:
Purchase the Newglab Pharma Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Newglab Pharma Co., Ltd. report to view the information.
Incorporation Date:
February 24, 2004
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
12%
Purchase this report to view the information.
4.9%
Subsidiaries
Aiting Art (Tianjin) Technology Co Ltd
100%
Newg Lab Pharma Inc
100%
뉴지랩파마코리아(주)
100%
Company Performance
Financial values in the chart are available after Newglab Pharma Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-58.8%
Total operating revenue
-57.83%
Operating profit (EBIT)
N/A
EBITDA
31.32%
Net Profit (Loss) for the Period
-28.53%
Total assets
-48.44%
Total equity
22.52%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-109.03%
Return on Equity (ROE)
13.66%
Debt to Equity Ratio
53.43%
Quick Ratio
-0.12%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?